Insulin Analog [EPC]

449301 reported adverse events

Drugs of this class: INSULIN ASPART INSULIN LISPRO INSULIN GLARGINE INSULIN DEGLUDEC INSULIN GLARGINE-YFGN INSULIN GLARGINE-AGLR INSULIN GLARGINE-ALDY INSULIN LISPRO-AABC WATER INJECTION ATTENTION DEFICIT MILD DROPS ATTENTION DEFICIT SEVERE DROPS

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 77778
1 DRUG INEFFECTIVE 21711
2 OFF LABEL USE 20267
3 BLOOD GLUCOSE DECREASED 19425
4 NAUSEA 18556
5 INCORRECT DOSE ADMINISTERED 14874
6 VISUAL IMPAIRMENT 14387
7 HYPOGLYCAEMIA 13384
8 FATIGUE 13362
9 DIARRHOEA 13358
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOGLYCAEMIC UNCONSCIOUSNESS 1198 0.6044
1 DEVICE OPERATIONAL ISSUE 2127 0.4940
2 DIABETIC RETINOPATHY 1618 0.4759
3 BLOOD GLUCOSE FLUCTUATION 4718 0.4301
4 BLOOD GLUCOSE INCREASED 77778 0.4124
5 BLOOD GLUCOSE DECREASED 19425 0.4041
6 BLOOD GLUCOSE ABNORMAL 6734 0.3642
7 DIABETES MELLITUS INADEQUATE CONTROL 6311 0.3561
8 PRODUCT STORAGE ISSUE 1327 0.3499
9 GLYCOSYLATED HAEMOGLOBIN INCREASED 7999 0.3166
See all enriched reactions for Insulin Analog [EPC]